Gregg Williams is Director & 10% Owner at SECOND SIGHT MEDICAL PRODUCTS INC (EYES). They have made 73 open-market trades across 2 companies since 2014, most recently 2026-07-15.
CIK 0001624919
73 open-market purchases totalling $111.6M since 2014, never a sale. Across 73 scored buys the stock is up 31.5% at ninety days, and 24.9 points ahead of the S&P over the same stretch.
73 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| EYES | 11,237,147 | $338.4M |
| VANI | 36,912,736 | $42.1M |
| Total | $380.4M |
Shares reported on the most recent Form 4, priced at the 2026-07-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 49% | 56% |
| Avg Move | +3.5% | +7.2% | +31.5% |
| Alpha | +3.2% | +5.5% | +24.9% |
| Scored | 73 | 73 | 73 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VANI | BUY | 2026-07-15 | 2026-07-16 | $1.26 | $1000K | -0.4% | +3.8% | -10.7% |
| VANI | BUY | 2026-06-15 | 2026-06-16 | $1.26 | $2.0M | +1.7% | +14.9% | +6.8% |
| VANI | BUY | 2026-05-15 | 2026-05-19 | $1.26 | $2.0M | +10.7% | -0.4% | +16.2% |
| VANI | BUY | 2026-04-15 | 2026-04-16 | $1.26 | $2.0M | -1.8% | -18.6% | +1.8% |
| VANI | BUY | 2026-03-15 | 2026-03-16 | $1.07 | $1.7M | -12.2% | -7.3% | -7.3% |
| VANI | BUY | 2026-02-15 | 2026-02-17 | $1.06 | $2.0M | -3.1% | -9.4% | -10.2% |
| VANI | BUY | 2026-01-27 | 2026-01-28 | $1.48 | $2.0M | -15.7% | -19.6% | -10.1% |
| VANI | BUY | 2026-01-15 | 2026-01-20 | $1.14 | $2.0M | -1.4% | -7.8% | +7.1% |
| VANI | BUY | 2025-12-15 | 2025-12-16 | $1.14 | $4.0M | -13.8% | -13.1% | -15.9% |
| VANI | BUY | 2025-11-15 | 2025-11-17 | $1.13 | $3.6M | -8.1% | -8.8% | -14.9% |
| VANI | BUY | 2025-10-27 | 2025-10-28 | $1.62 | $12.0M | -12.6% | -21.8% | -20.7% |
| VANI | BUY | 2025-10-15 | 2025-10-16 | $1.13 | $3.6M | +11.3% | -2.0% | -15.3% |
| VANI | BUY | 2025-09-15 | 2025-09-17 | $1.16 | $4.8M | -9.1% | +9.7% | -8.4% |
| VANI | BUY | 2025-05-14 | 2025-05-16 | $1.01 | $13K | +15.4% | +9.6% | +22.1% |
| VANI | BUY | 2025-04-24 | 2025-04-28 | $1.01 | $1K | -1.9% | +9.6% | +53.8% |
| VANI | BUY | 2025-04-21 | 2025-04-23 | $1.01 | $2K | +1.0% | +10.8% | +52.9% |
| VANI | BUY | 2025-04-09 | 2025-04-11 | $1.02 | $21K | +1.0% | +1.0% | +24.5% |
| VANI | BUY | 2025-04-04 | 2025-04-08 | $1.00 | $327K | +0.0% | +0.0% | +24.5% |
| VANI | BUY | 2025-04-02 | 2025-04-04 | $1.00 | $25K | +6.1% | +4.0% | +27.3% |
| VANI | BUY | 2024-11-08 | 2024-11-13 | $1.26 | $10.0M | -2.8% | -7.1% | -19.1% |
| VANI | BUY | 2024-02-15 | 2024-02-20 | $1.01 | $1K | +188.8% | +89.7% | +72.0% |
| VANI | BUY | 2024-02-08 | 2024-02-09 | $1.01 | $2K | +5.8% | +87.4% | +67.0% |
| VANI | BUY | 2024-02-05 | 2024-02-06 | $1.01 | $2K | +6.4% | +106.9% | +77.2% |
| VANI | BUY | 2024-01-31 | 2024-02-02 | $1.01 | $101 | +5.8% | +139.8% | +67.0% |
| VANI | BUY | 2024-01-23 | 2024-01-25 | $1.01 | $842 | +1.0% | +0.5% | +69.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.